Target intelligence / Profile preview

Synapse function

Molecular classification
Ion channel, G protein-coupled receptor, Transporter, Enzyme, Cell adhesion molecule
01

Overview

Synapse function is a complex physiological process rather than a single molecular target. It represents the communication mechanism between neurons, involving the release of neurotransmitters from the pre-synaptic terminal, their diffusion across the synaptic cleft, and subsequent binding to receptors on the post-synaptic membrane (StatPearls, 2023). This process is fundamental to all nervous system activities, including sensory perception, motor control, and higher-order cognition such as learning and memory (NINDS, 2023). Dysregulation of synaptic function, often referred to as synaptopathy, is a central feature of many neurological disorders, where the loss of synaptic density or impaired plasticity leads to clinical symptoms (Nature Reviews Neuroscience, 2014). In drug discovery, 'Synapse function' is too broad to be a specific target; instead, therapeutics are designed to interact with individual components such as ion channels, G protein-coupled receptors (GPCRs), or neurotransmitter transporters to modulate the overall efficiency of the synaptic signal (NCBI, 2022). Consequently, while it is the focus of intense therapeutic interest, it serves as a functional category for a multitude of specific molecular targets.

Other names
Synaptic transmissionNeurotransmissionSynaptic signalingSynaptic plasticity
02

Mechanism of action

Modulation of neurotransmitter reuptake, agonism or antagonism of post-synaptic receptors, inhibition of neurotransmitter degradation, and regulation of synaptic vesicle release (e.g., SV2A binding).

03

Biological functions

Signal transductionSynaptic plasticityNeurotransmitter releaseLearning and memoryAction potential propagation
04

Disease associations

Neurodegenerative diseaseEpilepsySchizophreniaMajor depressive disorderAutism spectrum disorder
05

Safety considerations

NeurotoxicityCognitive impairmentDrug dependencySeizure threshold alterationPsychosis
06

Interacting drugs

Fluoxetine

4 more in the full profile.

07

Biomarkers

Synaptic vesicle protein 2A (SV2A) PET imagingCerebrospinal fluid Synaptotagmin-1NeurograninGAP-43

Beyond the preview

Go deeper on Synapse function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synapse function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call